Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
Authors:
- 1 February 1989
- journal article
- research article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 80 (2) , 167-172
Abstract
The correlations of the 5‐fluorouracil (5‐FU) level in the plasma and the duration of continuous 5‐FU infusion with the antitumor activity of 5‐FU on Yoshida sarcomas in rats were examined. The circadian variation in the plasma level of 5‐FU during continuous infusion was prevented by treatment with 3‐cyano‐2,6‐dihydroxypyridine (CNDP), which strongly inhibits 5‐FU degradation. On continuous venous infusion of 2 to 30 mg/kg of 5‐FU over 24 h with CNDP at a molar ratio of 1:10 into normal rats, the 5‐FU level in the blood was linearly proportional to the dose of 5‐FU. The optimum schedule for antitumor activity on Yoshida sarcomas in rats was found to be infusion of 5‐FU at 5 mg/kg over 24 h for 6 consecutive days, which gave a plasma 5‐FU level of 176 ng/ml. Continuous infusion of 5‐FU to give a plasma level of 300 ng/ml for 6 consecutive days from day 5 after implantation of tumor cells, when the tumors weighed about 1.0 g, resulted in complete regression of the tumors in all rats.Keywords
This publication has 22 references indexed in Scilit:
- METABOLITES OF 5-FLUOROURACIL IN PLASMA AND URINE, AS MONITORED BY F-19 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY, FOR PATIENTS RECEIVING CHEMOTHERAPY WITH OR WITHOUT METHOTREXATE PRETREATMENT1988
- CIRCADIAN RHYTHM-VARYING PLASMA-CONCENTRATION OF 5-FLUOROURACIL DURING A 5-DAY CONTINUOUS VENOUS INFUSION AT A CONSTANT RATE IN CANCER-PATIENTS1988
- CLINICAL PHARMACOKINETICS OF 5-FLUOROURACIL AND ITS METABOLITES IN PLASMA, URINE, AND BILE1987
- CELLULAR BASIS FOR THE INEFFICACY OF 5-FU IN HUMAN-COLON CARCINOMA1985
- 5-FU INFUSION IN ADVANCED COLORECTAL-CANCER - A COMPARISON OF 3 DOSE SCHEDULES1985
- LONG-TERM, AMBULATORY, CONTINUOUS IV INFUSION OF 5-FU FOR THE TREATMENT OF ADVANCED ADENOCARCINOMAS1985
- Protracted ambulatory venous infusion of 5-fluorouracilAmerican Journal of Clinical Oncology, 1983
- PROTRACTED AMBULATORY VENOUS INFUSION OF 5-FLUOROURACIL1983
- A Rapid High-Performance Liquid Chromatographic Method for Quantitation of 5-Fluorouracil in Plasma after Continuous Intravenous InfusionAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
- Allopurinol modulation of fluorouracil toxicityCancer Chemotherapy and Pharmacology, 1981